{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T22:32:12Z","timestamp":1770762732706,"version":"3.50.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.aohep.2024.101572","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T14:03:44Z","timestamp":1726236224000},"page":"101572","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Study on the prediction model of liver cancer based on chronic liver disease and the related molecular mechanism"],"prefix":"10.1016","volume":"30","author":[{"given":"Xiaojing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinye","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.aohep.2024.101572_bib0001","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"10.1016\/j.aohep.2024.101572_bib0002","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41571-018-0073-4","article-title":"Molecular therapies and precision medicine for hepatocellular carcinoma","volume":"15","author":"Llovet","year":"2018","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"5","key":"10.1016\/j.aohep.2024.101572_bib0003","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1053\/j.gastro.2023.01.033","article-title":"Global epidemiology and genetics of hepatocellular carcinoma","volume":"164","author":"Toh","year":"2023","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.aohep.2024.101572_bib0004","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.aohep.2024.101572_bib0005","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/hep.27969","article-title":"World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma","volume":"62","author":"de Martel","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2024.101572_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2022.100809","article-title":"Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis: HCC and Steatosis or Steatohepatitis","volume":"30","author":"Petrelli","year":"2022","journal-title":"Neoplasia"},{"issue":"32","key":"10.1016\/j.aohep.2024.101572_bib0007","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.2217\/fon-2020-0669","article-title":"Systemic adjuvant treatment in hepatocellular carcinoma: tempted to do something rather than nothing","volume":"16","author":"Rizzo","year":"2020","journal-title":"Future Oncol"},{"issue":"2","key":"10.1016\/j.aohep.2024.101572_bib0008","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/j.gastro.2018.08.065","article-title":"Epidemiology and management of hepatocellular carcinoma","volume":"156","author":"Kulik","year":"2019","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.aohep.2024.101572_bib0009","doi-asserted-by":"crossref","first-page":"5039","DOI":"10.1007\/s10238-023-01159-1","article-title":"The impact of ECOG performance status on efficacy of immunotherapy and immune-based combinations in cancer patients: the MOUSEION-06 study","volume":"23","author":"Mollica","year":"2023","journal-title":"Clin Exp Med"},{"issue":"3","key":"10.1016\/j.aohep.2024.101572_bib0010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study","volume":"2","author":"Polaris Observatory","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.aohep.2024.101572_bib0011","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrgastro.2013.107","article-title":"Epidemiology and natural history of HCV infection","volume":"10","author":"Hajarizadeh","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2024.101572_bib0012","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.addr.2017.10.011","article-title":"Epigenetic reprogramming in liver fibrosis and cancer","volume":"121","author":"Wilson","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"10.1016\/j.aohep.2024.101572_bib0013","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/cr.2016.23","article-title":"Single-cell triple omics sequencing reveals genetic, epigenetic, and transcriptomic heterogeneity in hepatocellular carcinomas","volume":"26","author":"Hou","year":"2016","journal-title":"Cell Res"},{"issue":"3","key":"10.1016\/j.aohep.2024.101572_bib0014","doi-asserted-by":"crossref","first-page":"e9749","DOI":"10.1371\/journal.pone.0009749","article-title":"Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors","volume":"5","author":"Hernandez-Vargas","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.aohep.2024.101572_bib0015","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/1476-4598-13-196","article-title":"Clinical relevance and therapeutic potential of angiopoietin-like protein 4 in hepatocellular carcinoma","volume":"13","author":"Ng","year":"2014","journal-title":"Mol Cancer"},{"key":"10.1016\/j.aohep.2024.101572_bib0016","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejca.2022.03.010","article-title":"An elevated FIB-4 score is associated with an increased incidence of liver cancer: a longitudinal analysis among 248,224 outpatients in Germany","volume":"168","author":"Loosen","year":"2022","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.aohep.2024.101572_bib0017","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12916-021-02201-3","article-title":"Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma","volume":"20","author":"Luo","year":"2022","journal-title":"BMC Med"},{"issue":"6","key":"10.1016\/j.aohep.2024.101572_bib0018","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.jhep.2014.07.017","article-title":"Circulating microRNAs as markers of liver inflammation, fibrosis and cancer","volume":"61","author":"Roderburg","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2024.101572_bib0019","article-title":"Cuproptosis-related risk score predicts prognosis and characterizes the tumor microenvironment in hepatocellular carcinoma","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.aohep.2024.101572_bib0020","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.trecan.2020.02.007","article-title":"Promoter DNA hypermethylation and paradoxical gene activation","volume":"6","author":"Smith","year":"2020","journal-title":"Trends Cancer"},{"issue":"3","key":"10.1016\/j.aohep.2024.101572_bib0021","first-page":"1535","article-title":"Role of kynurenine in promoting the generation of exhausted CD8(+) T cells in colorectal cancer","volume":"13","author":"Wu","year":"2021","journal-title":"Am J Transl Res"},{"issue":"1","key":"10.1016\/j.aohep.2024.101572_bib0022","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1158\/1078-0432.CCR-20-2166","article-title":"An immune-related gene prognostic index for head and neck squamous cell carcinoma","volume":"27","author":"Chen","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.aohep.2024.101572_bib0023","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1042\/EBC20190037","article-title":"The DNA methylation landscape in cancer","volume":"63","author":"Skvortsova","year":"2019","journal-title":"Essays Biochem"},{"issue":"6990","key":"10.1016\/j.aohep.2024.101572_bib0024","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nature02625","article-title":"Epigenetics in human disease and prospects for epigenetic therapy","volume":"429","author":"Egger","year":"2004","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.aohep.2024.101572_bib0025","doi-asserted-by":"crossref","first-page":"e352","DOI":"10.1016\/S1470-2045(15)00078-9","article-title":"Recommendations for screening and early detection of common cancers in India","volume":"16","author":"Rajaraman","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.aohep.2024.101572_bib0026","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1038\/ncomms9699","article-title":"A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma","volume":"6","author":"Wei","year":"2015","journal-title":"Nat Commun"},{"issue":"28","key":"10.1016\/j.aohep.2024.101572_bib0027","doi-asserted-by":"crossref","first-page":"7414","DOI":"10.1073\/pnas.1703577114","article-title":"DNA methylation markers for diagnosis and prognosis of common cancers","volume":"114","author":"Hao","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.aohep.2024.101572_bib0028","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13030545","article-title":"Role of methylation in pro- and anti-cancer immunity","volume":"13","author":"Mehdi","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.aohep.2024.101572_bib0029","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/biom.13792","article-title":"Instrumental variable estimation of the causal hazard ratio","volume":"79","author":"Wang","year":"2023","journal-title":"Biometrics"},{"issue":"2","key":"10.1016\/j.aohep.2024.101572_bib0030","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/pst.1973","article-title":"Determination of hazard ratio for progression-free survival considering the tumor assessment schedule in sample size calculation","volume":"19","author":"Tanase","year":"2020","journal-title":"Pharm Stat"},{"issue":"8","key":"10.1016\/j.aohep.2024.101572_bib0031","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1128\/AAC.48.8.2787-2792.2004","article-title":"Hazard ratio in clinical trials","volume":"48","author":"Spruance","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.aohep.2024.101572_bib0032","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12885-019-5321-1","article-title":"Risk prediction for breast cancer in han chinese women based on a cause-specific hazard model","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.aohep.2024.101572_bib0033","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1038\/oncsis.2015.49","article-title":"Lipid metabolic reprogramming in cancer cells","volume":"5","author":"Beloribi-Djefaflia","year":"2016","journal-title":"Oncogenesis"},{"issue":"2","key":"10.1016\/j.aohep.2024.101572_bib0034","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2174\/1871520616666161031143301","article-title":"The Warburg effect and the hallmarks of cancer","volume":"17","author":"Schwartz","year":"2017","journal-title":"Anticancer Agents Med Chem"},{"issue":"3","key":"10.1016\/j.aohep.2024.101572_bib0035","doi-asserted-by":"crossref","first-page":"e12772","DOI":"10.1111\/cpr.12772","article-title":"Aberrant lipid metabolism in hepatocellular carcinoma cells as well as immune microenvironment: a review","volume":"53","author":"Hu","year":"2020","journal-title":"Cell Prolif"},{"issue":"7","key":"10.1016\/j.aohep.2024.101572_bib0036","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.aohep.2024.101572_bib0037","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/TP.0000000000002480","article-title":"Nonalcoholic fatty liver disease: basic pathogenetic mechanisms in the progression from NAFLD to NASH","volume":"103","author":"Pierantonelli","year":"2019","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.aohep.2024.101572_bib0038","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.immuni.2015.09.001","article-title":"Metabolic reprogramming of immune cells in cancer progression","volume":"43","author":"Biswas","year":"2015","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.aohep.2024.101572_bib0039","doi-asserted-by":"crossref","DOI":"10.3390\/cells8050512","article-title":"Characterization of lipid and lipid droplet metabolism in human HCC","volume":"8","author":"Berndt","year":"2019","journal-title":"Cells"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268124003557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268124003557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T09:31:48Z","timestamp":1764667908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268124003557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1665268124003557"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2024.101572","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Study on the prediction model of liver cancer based on chronic liver disease and the related molecular mechanism","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2024.101572","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101572"}}